ProfileGDS4718 / 232929_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 62% 72% 60% 61% 68% 56% 55% 60% 65% 62% 58% 67% 58% 55% 55% 59% 63% 56% 57% 69% 60% 65% 63% 62% 61% 62% 70% 72% 75% 50% 61% 58% 70% 63% 65% 55% 55% 65% 69% 60% 64% 62% 65% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.261962
GSM549102patient 115, normal, homogenized [OPG study]7.0039972
GSM549104patient 119, normal, homogenized [OPG study]6.1351660
GSM549108patient 138, normal, homogenized [OPG study]6.2025461
GSM549119patient 077, normal, homogenized [OPG study]6.6907468
GSM549133patient 032, cancer, homogenized [OPG study]5.8409856
GSM549139patient 042, cancer, homogenized [OPG study]5.803155
GSM549099patient 107, normal, homogenized [OPG study]6.1362160
GSM549109patient 139, normal, homogenized [OPG study]6.4886665
GSM549110patient 046, normal, homogenized [OPG study]6.2708862
GSM549114patient 063, normal, homogenized [OPG study]5.9268558
GSM549122patient 082, normal, homogenized [OPG study]6.6343967
GSM549134patient 033, cancer, homogenized [OPG study]5.9707158
GSM549136patient 036, cancer, homogenized [OPG study]5.7586355
GSM549140patient 044, cancer, homogenized [OPG study]5.7915155
GSM549111patient 047, normal, homogenized [OPG study]6.075659
GSM549113patient 057, normal, homogenized [OPG study]6.2932963
GSM549132patient 031, cancer, homogenized [OPG study]5.8543856
GSM549137patient 038, cancer, homogenized [OPG study]5.942757
GSM549142patient 047, cancer, homogenized [OPG study]6.795669
GSM549100patient 110, normal, homogenized [OPG study]6.1287560
GSM549107patient 135, normal, homogenized [OPG study]6.4666465
GSM549115patient 068, normal, homogenized [OPG study]6.2900663
GSM549116patient 072, normal, homogenized [OPG study]6.3000162
GSM549120patient 078, normal, homogenized [OPG study]6.207961
GSM549131patient 030, cancer, homogenized [OPG study]6.2636162
GSM549118patient 074, normal, homogenized [OPG study]6.9240470
GSM549129patient 027, cancer, homogenized [OPG study]7.0703372
GSM549123patient 088, normal, homogenized [OPG study]7.308175
GSM549124patient 006, cancer, homogenized [OPG study]5.5533650
GSM549126patient 015, cancer, homogenized [OPG study]6.186161
GSM549128patient 025, cancer, homogenized [OPG study]6.0373758
GSM549103patient 117, normal, homogenized [OPG study]6.8379670
GSM549117patient 073, normal, homogenized [OPG study]6.255563
GSM549138patient 041, cancer, homogenized [OPG study]6.5270665
GSM549141patient 045, cancer, homogenized [OPG study]5.7784755
GSM549130patient 028, cancer, homogenized [OPG study]5.819955
GSM549101patient 111, normal, homogenized [OPG study]6.5364565
GSM549105patient 128, normal, homogenized [OPG study]6.8167369
GSM549106patient 134, normal, homogenized [OPG study]6.0714360
GSM549112patient 048, normal, homogenized [OPG study]6.3624764
GSM549125patient 011, cancer, homogenized [OPG study]6.2603862
GSM549127patient 024, cancer, homogenized [OPG study]6.5637265
GSM549135patient 035, cancer, homogenized [OPG study]5.8726856